A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Cancer Med
; 10(18): 6354-6364, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34374489
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Prostatic Neoplasms, Castration-Resistant
/
Abiraterone Acetate
/
Docetaxel
/
Androgen Antagonists
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2021
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Estados Unidos